Alzheimers Drug Discovery Foundation is located in New York, NY. The organization was established in 2005. According to its NTEE Classification (V36) the organization is classified as: Gerontology, under the broad grouping of Social Science and related organizations. As of 12/2021, Alzheimers Drug Discovery Foundation employed 37 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Alzheimers Drug Discovery Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Alzheimers Drug Discovery Foundation generated $53.0m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 13.1% each year . All expenses for the organization totaled $37.1m during the year ending 12/2021. While expenses have increased by 16.0% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Alzheimers Drug Discovery Foundation has awarded 171 individual grants totaling $119,161,168. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT AND TREAT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
EXEMPT PURPOSE ACHIEVEMENT IS TO ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT AND TREAT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS THROUGH THE GRANTING OF FUNDS TO ORGANIZATIONS AND THE SPONSORSHIP OF CONFERENCES THAT BRING TOGETHER ACADEMIC AND BIO TECHNOLOGY SCIENTISTS CONDUCTING DRUG DISCOVERY RESEARCH IN THE FIELD OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Howard Fillit MD Founding Ex Dir | OfficerTrustee | 36 | $608,395 |
Mark Roithmayr CEO | Officer | 16 | $369,658 |
Janie Shissler Scientist | 40 | $298,403 | |
Mark Forman Scientist | 40 | $282,839 | |
Shobha Prushothama Scientist | 40 | $211,734 | |
Karen Harris CFO | Trustee | 20 | $110,180 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Beacon Hill Staffing Group Llc Recruitment | 12/30/21 | $141,549 |
Mcdermott & Bull Llc Recruitment | 12/30/21 | $118,900 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $2,115,709 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $39,497,031 |
Noncash contributions included in lines 1a–1f | $252,473 |
Total Revenue from Contributions, Gifts, Grants & Similar | $41,612,740 |
Total Program Service Revenue | $9,141,360 |
Investment income | $206,491 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $2,076,513 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $53,037,104 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $31,052,095 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $608,395 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $2,782,911 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $944,832 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $713,081 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $216,997 |
Advertising and promotion | $0 |
Office expenses | $203,736 |
Information technology | $164,392 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $43,175 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $67,723 |
Total functional expenses | $37,126,176 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $10,342,550 |
Savings and temporary cash investments | $24,683,523 |
Pledges and grants receivable | $29,947,933 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $72,474 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $51,304,846 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $68,749 |
Total assets | $116,420,075 |
Accounts payable and accrued expenses | $347,274 |
Grants payable | $51,494,985 |
Deferred revenue | $536,143 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $52,378,402 |
Net assets without donor restrictions | $33,483,278 |
Net assets with donor restrictions | $30,558,395 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $116,420,075 |
Over the last fiscal year, Alzheimers Drug Discovery Foundation has awarded $35,117,767 in support to 34 organizations.
Grant Recipient | Amount |
---|---|
NEURO THERAPIA INC PURPOSE: ALZHEIMER'S RESEARCH | $3,000,000 |
METRO INTL BIOTECHEDENROC PURPOSE: ALZHEIMER'S RESEARCH | $3,000,000 |
Sausalito, CA PURPOSE: ALZHEIMER'S RESEARCH | $2,500,000 |
NEUROVISION IMAGING PURPOSE: ALZHEIMER'S RESEARCH | $2,200,950 |
NEROVISION IMAGING INC PURPOSE: ALZHEIMER'S RESEARCH | $2,200,950 |
OPTINA DIAGNOSTICS PURPOSE: ALZHEIMER'S RESEARCH | $2,135,000 |
Over the last fiscal year, we have identified 4 grants that Alzheimers Drug Discovery Foundation has recieved totaling $13,000.
Awarding Organization | Amount |
---|---|
Lewis Fam Tr Palm Beach, FL PURPOSE: PRESELECTED ORGANIZATIONS | $10,000 |
David B Kriser Foundation Inc New York, NY PURPOSE: GENERAL CONTRIBUTION | $1,000 |
Daelansa Foundation Palm Beach, FL PURPOSE: USE FOR THEIR STATED PURPOSE. | $1,000 |
Harold Plotnek Charitable Foundation Inc Bethesda, MD PURPOSE: CHARITABLE CONTRIBUTION | $1,000 |
Organization Name | Assets | Revenue |
---|---|---|
Alzheimers Drug Discovery Foundation New York, NY | $116,420,075 | $53,037,104 |
American Federation For Aging New York, NY | $30,014,800 | $13,781,782 |
Central Massachusetts Agency On Aging Inc Worcester, MA | $2,752,139 | $4,874,436 |
Margaret D Smock Charitable Trust Pittsburgh, PA | $4,335,445 | $403,159 |
Kendal Fund Kennett Square, PA | $5,128,306 | $226,039 |